<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Spring Hill Practice</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
            in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
            mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
            population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
        </p>
        <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
            it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
        </p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=practice+Y03049">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
            send short or detailed feedback.
        </p>
        <h2>Prescribing where Spring Hill Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0203020G0&amp;denomIds=2.3.2&amp;selectedTab=summary">Disopyramide phosphate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Drugs for arrhythmias</td>
      <td>6</td>
      <td>0.50</td>
      <td>0.00</td>
      <td>0.03</td>
      <td>17.95</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0203020G0AAACAC&amp;denomIds=2.3.2&amp;selectedTab=summary" target="_blank">Disopyramide 250mg modified-release tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601021X0&amp;denomIds=6.1.2&amp;selectedTab=summary">Tolbutamide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>92</td>
      <td>Sulfonylureas</td>
      <td>582</td>
      <td>0.16</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>14.48</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601021X0AAADAD&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Tolbutamide 500mg tablets : 92</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601023R0&amp;denomIds=6.1.2&amp;selectedTab=summary">Repaglinide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>71</td>
      <td>Other antidiabetic drugs</td>
      <td>569</td>
      <td>0.12</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>11.53</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601023R0AAACAC&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Repaglinide 2mg tablets : 36</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601023R0BCABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Prandin 1mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601023R0AAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Repaglinide 1mg tablets : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601023R0AAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Repaglinide 500microgram tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=1001040K0&amp;denomIds=10.1.4&amp;selectedTab=summary">Probenecid</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Gout and cytotoxic induced hyperiuicaemia</td>
      <td>151</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=1001040K0AAAAAA&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Probenecid 500mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011N0&amp;denomIds=6.1.1&amp;selectedTab=summary">Soluble insulin (Neutral insulin)</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>42</td>
      <td>Short-acting insulins</td>
      <td>230</td>
      <td>0.18</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>7.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011N0BHADAP&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Humulin S 100units/ml solution for injection 3ml cartridges : 42</a></div></td></tr></tbody></table>

        <h2>Prescribing where Spring Hill Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601040I0&amp;denomIds=6.1.4&amp;selectedTab=summary">Glucose</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Treatment of hypoglycaemia</td>
      <td>11</td>
      <td>0.18</td>
      <td>0.75</td>
      <td>0.21</td>
      <td>-2.75</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601040I0BBABAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GlucoGel 40% gel original : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0212000Y0&amp;denomIds=2.12&amp;selectedTab=summary">Simvastatin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>84</td>
      <td>Lipid-regulating drugs</td>
      <td>3393</td>
      <td>0.02</td>
      <td>0.22</td>
      <td>0.08</td>
      <td>-2.60</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0212000Y0AAADAD&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Simvastatin 40mg tablets : 43</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0212000Y0AAABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Simvastatin 20mg tablets : 28</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0212000Y0AAAHAH&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Simvastatin 80mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0212000Y0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Simvastatin 10mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0602020D0&amp;denomIds=6.2.2&amp;selectedTab=summary">Carbimazole</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>18</td>
      <td>Antithyroid drugs</td>
      <td>27</td>
      <td>0.67</td>
      <td>0.93</td>
      <td>0.11</td>
      <td>-2.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0602020D0AAAYAY&amp;denomIds=6.2.2&amp;selectedTab=summary" target="_blank">Carbimazole 10mg tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0602020D0AAAAAA&amp;denomIds=6.2.2&amp;selectedTab=summary" target="_blank">Carbimazole 5mg tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0602020D0AAABAB&amp;denomIds=6.2.2&amp;selectedTab=summary" target="_blank">Carbimazole 20mg tablets : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011A0&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin aspart</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>117</td>
      <td>Short-acting insulins</td>
      <td>230</td>
      <td>0.51</td>
      <td>0.79</td>
      <td>0.12</td>
      <td>-2.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011A0BBADAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid FlexPen 100units/ml inj 3ml pre-filled pens : 68</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011A0BCAAAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Fiasp FlexTouch 100units/ml inj 3ml pre-filled pens : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011A0BBAEAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid FlexTouch 100units/ml inj 3ml pre-filled pens : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011A0BBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid 100units/ml solution for injection 10ml vials : 23</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0601011A0BBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid Penfill 100units/ml inj 3ml cartridges : 23</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0205010J0&amp;denomIds=2.5.1&amp;selectedTab=summary">Hydralazine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Vasodilator antihypertensive drugs</td>
      <td>10</td>
      <td>0.20</td>
      <td>0.85</td>
      <td>0.28</td>
      <td>-2.30</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=Y03049&amp;numIds=0205010J0AAAGAG&amp;denomIds=2.5.1&amp;selectedTab=summary" target="_blank">Hydralazine 25mg tablets : 2</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>